MolNFT v1 · #69180 · protein
The crystal structures of 2-aminobenzothiazole-based inhibitors in complexes with urokinase-type plasminogen activator
3KID: “The crystal structures of 2-aminobenzothiazole-based inhibitors in complexes with urokinase-type plasminogen…”. X-ray diffraction, 1 ligand (2BS), 1 pocket (best druggability 0.37). MolNFT v1 #69180 on GenesisL1: 3D structure…
- PDB
- 3KID
- Type
- protein
- Length
- 238 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Urokinase-type plasminogen activator
- EC
- 3.4.21.73
- UniProt
- P00749
- Ligands
- 2BS
- Pockets
- 1 · best druggability 0.37
Structure
x-ray diffraction · 1 distinct chain · 12% helix, 39% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| U | Urokinase-type plasminogen activator (EC 3.4.21.73) | protein | 238 | 12% helix, 39% strand | P00749 |
Ligands and binding sites
- 2BS · ethyl 2-amino-1,3-benzothiazole-6-carboxylate · ligand · chains U
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 85 | 0.37 | 0.77 | 26 | 2BS |
Modifications
Observed in the structure: 5 disulfide (disulfide).
Compared structures
- 3KID · The Crystal Structures of 2-Aminobenzothiazole-based Inhibitors in Complexes with… · the same entry in another collection · chain U against U, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P00749
- Elsewhere: RCSB PDB 3KID · PDBe 3KID · UniProt P00749
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.